Literature DB >> 3459939

[HLA and thyroid cancer].

H Dralle, M Robin-Winn, L Reilmann, A Laue, M Török.   

Abstract

HLA typing was performed in 51 patients to analyse the pathogenetic background of differentiated and medullary thyroid carcinomas. A higher incidence of Bw62 and DR5 was observed in patients with papillary carcinoma (n = 24), DRw6 antigen in follicular carcinoma (n = 13), and DR3 antigen in patients with medullary carcinoma (n = 11). The DR3 antigen was present in one of two patients with a familial history of medullary thyroid carcinoma. Therefore, HLA typing is not suitable as a screening method for the detection of early thyroid carcinoma.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3459939     DOI： 10.1007/BF01713060

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  27 in total

1.  Pituitary adenoma, primary parathyroid hyperplasia and papillary (non-medullary) thyroid carcinoma. A case of multiple endocrine neoplasia (MEN).

Authors:  H Dralle; E Altenähr
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-02-09

2.  Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2.

Authors:  A L Steiner; A D Goodman; S R Powers
Journal:  Medicine (Baltimore)       Date:  1968-09       Impact factor: 1.889

3.  HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease.

Authors:  F C Grumet; R O Payne; J Konishi; J P Kriss
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

4.  [Papillary epithelioma of the thyroid gland. Apropos of 2 familial cases].

Authors:  J Lacour; J Vignalou; R Perez; R Gérard-Marchant
Journal:  Nouv Presse Med       Date:  1973-09-29

5.  Graves' disease and HLA: clinical and epidemiologic associations.

Authors:  N R Farid; E Stone; G Johnson
Journal:  Clin Endocrinol (Oxf)       Date:  1980-12       Impact factor: 3.478

6.  A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype.

Authors:  H Allannic; R Fauchet; Y Lorcy; M Gueguen; A M Le Guerrier; B Genetet
Journal:  J Clin Endocrinol Metab       Date:  1983-10       Impact factor: 5.958

7.  HLA antigens in Graves' disease.

Authors:  K Bech; B Lumholtz; J Nerup; M Thomsen; P Platz; L P Ryder; A Svejgaard; K Siersbaek-Nielsen; J M Hansen; J H Larsen
Journal:  Acta Endocrinol (Copenh)       Date:  1977-11

8.  Familial occurrence of differentiated (non-medullary) thyroid cancer.

Authors:  J Nĕmec; J Soumar; V Zamrazil; D Pohunková; K Motlík; P Mirejovský
Journal:  Oncology       Date:  1975       Impact factor: 2.935

9.  Gardner's syndrome with duodenal adenomas, gastric adenomyoma and thyroid papillary--follicular adenocarcinoma.

Authors:  A A Keshgegian; H T Enterline
Journal:  Dis Colon Rectum       Date:  1978 May-Jun       Impact factor: 4.585

Review 10.  Heterogeneity in diabetes mellitus--update, 1978. Evidence for further genetic heterogeneity within juvenile-onset insulin-dependent diabetes mellitus.

Authors:  J I Rotter; D L Rimoin
Journal:  Diabetes       Date:  1978-05       Impact factor: 9.461
View more
  3 in total

Review 1.  Familial occurrence of differentiated, nonmedullary thyroid carcinoma.

Authors:  O Ozaki; K Ito; K Kobayashi; A Suzuki; Y Manabe; Y Hosoda
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

2.  HLA-antigen distribution in seminoma, HCG-positive seminoma and non-seminomatous tumours of the testis.

Authors:  C Kratzik; P Aiginger; R Kuzmits; J Spona; M Kirnbauer; A Seiser; W R Mayr
Journal:  Urol Res       Date:  1989

3.  Association of HLA-B*51:01 with papillary thyroid carcinoma in the Chinese Han population of the Shandong coastal areas.

Authors:  Jiao Shuxian; Chi Xiaoyun; Feng Zhihui; Liu Xiaohua; Du Zhanhui; Hu Bin; Zhao Lin
Journal:  Thyroid       Date:  2014-01-30       Impact factor: 6.568
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.